Protalix BioTherapeutics to Present at Investor Summit Virtual

Core Viewpoint - Protalix BioTherapeutics, Inc. is set to present its growth strategies and market opportunities at the upcoming Investor Summit Virtual on September 16, 2025, led by former Sr. Vice President and Chief Financial Officer Eyal Rubin [1] Company Overview - Protalix BioTherapeutics focuses on the development, production, and commercialization of recombinant therapeutic proteins [1] - The company utilizes its proprietary ProCellEx® plant cell-based protein expression system for its biopharmaceutical products [1] Event Details - The Q3 Investor Summit presentation is scheduled for September 16, 2025, at 10:30 a.m. [1]